search

Active clinical trials for "Conjunctivitis"

Results 311-320 of 360

A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis...

Conjunctivitis

To engage in a multi-center, prospective, masked clinical trial to investigate a non-invasive, rapid diagnostic test, the RPS Adeno Detector IV's ability to detect the presence of the adenovirus (ADV) antigen in cases of acute conjunctivitis by comparing it to cell culture with confirmatory immunofluorescence (CC-IFA). The polymerase chain reaction (PCR) will be used as a referee for discrepant cases.

Completed9 enrollment criteria

Olopatadine Eye Drops and Allergy Skin Testing

Allergic RhinitisAllergic Conjunctivitis

Use of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.

Completed11 enrollment criteria

A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis

Allergic Conjunctivitis

This study will evaluate the safety and efficacy of a new allergy medication

Withdrawn7 enrollment criteria

Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis...

ConjunctivitisAllergic

This post-marketing surveillance study will assess the safety and efficacy of Lastacaft® Opthalmic Solution 0.25% (Alcaftadine) for the prevention of itching associated with Allergic Conjunctivitis as prescribed as standard of care in clinical practice in Korea.

Completed2 enrollment criteria

Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis...

ConjunctivitisAtopic Dermatitis

The primary objective of the study is to characterize the clinical phenotype(s) of DUPIXENT®-associated conjunctivitis events. The secondary objectives of the study are to characterize the course of conjunctivitis events during the observation period and collect and assess data on treatment for conjunctivitis events and its effectiveness.

Completed12 enrollment criteria

Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea

ConjunctivitisAllergic

This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of Relestat Ophthalmic Solution 0.05% in patients with allergic conjunctivitis who are treated with Relestat as standard of care in clinical practice.

Completed2 enrollment criteria

An Optional Investigation of Biomarkers of Efficacy

Rhinoconjunctivitis

House Dust Mites (HDM) are arachnids that infest bedding, carpet, upholstered furniture and fabric. Like many other allergens, exposure to HDMA in sensitised patients is associated with poorer lung function, greater medication requirements and more asthma symptoms as well as chronic rhinosinusitis symptoms. In contrast to other allergens, there is evidence that HDMA leads to the development of asthma, in addition to exacerbating pre-existing asthma in HDM-sensitised patients. ToleroMune House Dust Mite (TM-HDM) is being developed for the treatment of HDM allergy. Study TH002 evaluated the efficacy, safety and tolerability of TM-HDM. This study will identify cellular, proteomic or genetic biomarkers of efficacy to TM-HDM treatment in TH002 study participants

Completed2 enrollment criteria

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate...

Allergic Conjunctivitis

To compare the safety and tolerability of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% combination ophthalmic solution versus its vehicle in healthy adult subjects and in pediatric subjects.

Completed37 enrollment criteria

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis...

Allergy

Safety and tolerability of ORALAIR in children 5 to 9 years of age during the first 30 days of treatment.

Completed2 enrollment criteria

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients

Allergic Conjunctivitis

The purpose of this study is to descriptively evaluate the corneal structures of allergic conjunctivitis patients.

Completed27 enrollment criteria
1...313233...36

Need Help? Contact our team!


We'll reach out to this number within 24 hrs